Brief: Shirley Family Office Sends Letter To Plx Pharma Board
Feb 8 (Reuters) - SHIRLEY FAMILY OFFICE :
* SHIRLEY FAMILY OFFICE SENDS LETTER TO PLX PHARMA (PLXP)
BOARD OF
DIRECTORS
* SHIRLEY FAMILY OFFICE - ASKS PLX BOARD TO TERMINATE
CONVERTIBLE
PREFERRED STOCK FINANCING AND TO CONDUCT "PROPERLY MARKETED"
CAPITAL RAISE
* SHIRLEY FAMILY OFFICE SAYS OWNS MORE THAN 3% OF PLX PHARMA
INC.
("PLXP") COMMON SHARES
Source text for Eikon: ID:nBwXBM0qa
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice